August 22, 2016
Advising Medivation on its ~$14 billion sale to Pfizer Inc.
May 19, 2016
Advising FMC Technologies, Inc. on its ~$6.1 billion merger of equals with Technip SA LLC.
April 28, 2016
Advising Abbott Laboratories on its ~$31 billion acquisition of St. Jude Medical, Inc.
April 27, 2016
Advising the Special Committee of the Board of Facebook, Inc. on its proposed multi-class recapitalization.
April 18, 2016
Advised MGM Growth Properties on its $1.2 billion IPO – the third largest REIT IPO in history.
In the News
August 31, 2016
NEW YORK and SEOUL, August 31, 2016 – Evercore (NYSE: EVR), a leading independent investment banking advisory firm headquartered in New York, USA and NH Investment & Securities (“NH”), the leading South Korea-based investment bank, announced today they have extended their strategic alliance for cross-border M&A advisory services for an additional two year period and expanded it to operate on an exclusive basis between the U.S. and South Korea.more >
May 2, 2016
Michael Palm to Join Evercore as a Senior Managing Director in the Industrials Corporate Advisory Practice in Chicago
NEW YORK, May 2, 2016 – Evercore (NYSE:EVR) announced today that Michael Palm has agreed to join the Firm’s Investment Banking business as a Senior Managing Director. Mr. Palm will focus on Evercore’s global efforts in the industrials sector and will be based in Chicago.more >